Allstate Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Allstate Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$101K	Buy	+11,105	New	+$96.9K	﹤0.01%	577

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Allstate Investment Management's TEVA Position: Q4 2022 in Review

Allstate Investment Management opened a new position in Teva Pharmaceuticals (TEVA) in Q4 2022: 11,105 shares worth $101K. The stake represents ﹤0.01% of the portfolio and ranks #577 among its holdings.

421 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

Allstate Investment Management held 11,105 shares of Teva Pharmaceuticals worth $101K as of Q4 2022.
Teva Pharmaceuticals was a new Allstate Investment Management position in Q4 2022.
Teva Pharmaceuticals made up ﹤0.01% of Allstate Investment Management's portfolio in Q4 2022, its #577 holding.
421 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.